Literature DB >> 21233078

Differences in antibiotic prescribing in paediatric outpatients.

Antonio Clavenna1, Maurizio Bonati.   

Abstract

Antibiotics represent the most widely prescribed therapeutic agents. The prevalence of drug prescription differs across age, with preschool children being most exposed to antibiotic drugs, especially in the community setting. A review with the aim to compare the profile of antibiotic drug prescription at the multinational, national and regional levels was performed. This overview of drug-utilisation studies found quantitative and qualitative differences in the antibiotic prescription profile between and within countries. Moreover, differences exist also at the local level and between prescribers. In general, second-choice antibiotic drugs (eg, cephalosporins) were more commonly prescribed in settings characterised by a high prevalence of antibiotic prescription. Geographical differences should be taken into account when monitoring antimicrobial drug resistance and when planning educational interventions for health professionals and parents with the aim to improve the rational use of antibiotic drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233078     DOI: 10.1136/adc.2010.183541

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  46 in total

1.  Antibiotic prescribing trends in an omani paediatric population.

Authors:  Khalid Al-Balushi; Fatma Al-Ghafri; Fatma Al-Sawafi; Ibrahim Al-Zakwani
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

2.  The regional profile of antibiotic prescriptions in Italian outpatient children.

Authors:  Daniele Piovani; Antonio Clavenna; Massimo Cartabia; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2012-01-21       Impact factor: 2.953

3.  The Decline in Outpatient Antibiotic Use.

Authors:  Jakob Holstiege; Maike Schulz; Manas K Akmatov; Winfried V Kern; Annika Steffen; Jörg Bätzing
Journal:  Dtsch Arztebl Int       Date:  2020-10-09       Impact factor: 5.594

4.  Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.

Authors:  Laura M Cox; Shingo Yamanishi; Jiho Sohn; Alexander V Alekseyenko; Jacqueline M Leung; Ilseung Cho; Sungheon G Kim; Huilin Li; Zhan Gao; Douglas Mahana; Jorge G Zárate Rodriguez; Arlin B Rogers; Nicolas Robine; P'ng Loke; Martin J Blaser
Journal:  Cell       Date:  2014-08-14       Impact factor: 41.582

5.  Systemic antibiotic use among children and adolescents in Germany: a population-based study.

Authors:  Jakob Holstiege; Edeltraut Garbe
Journal:  Eur J Pediatr       Date:  2013-02-10       Impact factor: 3.183

6.  Formula feeding increases the risk of antibiotic prescriptions in children up to 2 years: results from a cohort study.

Authors:  Simona Di Mario; Carlo Gagliotti; Andrea Donatini; Sergio Battaglia; Rossella Buttazzi; Sara Balduzzi; Silvana Borsari; Vittorio Basevi; Luca Barbieri
Journal:  Eur J Pediatr       Date:  2019-09-06       Impact factor: 3.183

7.  Indicators show differences in antibiotic use between general practitioners and paediatricians.

Authors:  C Pulcini; C Lions; B Ventelou; P Verger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-30       Impact factor: 3.267

8.  Overtesting and overtreatment-statement from the European Academy of Paediatrics (EAP).

Authors:  Ketil Størdal; Corinne Wyder; Andreas Trobisch; Zachi Grossman; Adamos Hadjipanayis
Journal:  Eur J Pediatr       Date:  2019-09-10       Impact factor: 3.183

9.  Antibiotic and anti-asthmatic drug prescriptions in Italy: geographic patterns and socio-economic determinants at the district level.

Authors:  Daniele Piovani; Antonio Clavenna; Massimo Cartabia; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2013-12-06       Impact factor: 2.953

10.  Prescription drug dispensing profiles for one million children: a population-based analysis.

Authors:  Tingting Zhang; M Anne Smith; Pat G Camp; Salomah Shajari; Stuart M MacLeod; Bruce C Carleton
Journal:  Eur J Clin Pharmacol       Date:  2012-07-12       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.